M

M

MAZZA , Manuelita

Last name: MAZZA

First name: Manuelita

2022 (v1)

Publication

Metadata-only

Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2- Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 Study

De Laurentiis, Michelino Caputo, Roberta Mazza, Manuelita

Ribociclib plus letrozole demonstrated manageable safety and efficacy profiles in hormone receptor-positive (HR+), human epidermal growth factor receptor-2-negative (HER2-) advanced breast cancer (ABC) in the Phase 3b CompLEEment-1 trial.

Uploaded on: February 14, 2024